Pharma

Your Article Summary

See Latest Articles

Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Corporate News Releases - The Healthcare Sales & Marketing Network, 09/08/06

The weight loss medication Xenical(R) (orlistat) has been shown to significantly reduce weight and improve the control of glucose levels in the blood (glycaemia) beyond the impact of weight loss alone in overweight and obese people with type 2 diabetes, according to study results presented at the International Congress on Obesity (ICO) in Sydney, Australia

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
Clinical Cancer Research, 10/19/09

A Randomized Trial of Doxycycline for Mansonella perstans Infection
New England Journal of Medicine, 10/08/09

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
Trials, 10/28/09

See All of Drug Trials